Soliton, Inc. (SOLY)
Stock Price:
$8.55 USD
-0.08 (-0.93%)
Updated Oct 21, 2020 4:00 PM EDT - Market closed
Pre-market: $8.13 -0.42 (-4.91%) Oct 22, 4:00 AM
Key Info
| Market Cap |
181.17M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-13.98M |
| Shares Out |
21.19M |
| EPS (ttm) |
-0.84 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 21, 2020 |
| Last Price |
$8.55 |
| Previous Close |
$8.63 |
| Change ($) |
-0.08 |
| Change (%) |
-0.93% |
| Day's Open |
8.56 |
| Day's Range |
8.39 - 8.82 |
| Day's Volume |
32 |
| 52-Week Range |
5.69 - 15.50 |
More Stats
| Market Cap |
181.17M |
| Enterprise Value |
143.67M |
| Earnings Date (est) |
Nov 5, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
21.19M |
| Float |
10.06M |
| EPS (basic) |
-0.82 |
| EPS (diluted) |
-0.84 |
| FCF / Share |
-0.69 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
1.93M |
| Short Ratio |
8.74 |
| Short % of Float |
19.17% |
| Beta |
n/a |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
4.57 |
| Revenue |
n/a |
| Operating Income |
-13.99M |
| Net Income |
-13.98M |
| Free Cash Flow |
-11.66M |
| Net Cash |
37.51M |
| Net Cash / Share |
1.77 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-33.75% |
| ROE |
-58.08% |
| ROIC |
1,438.50% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (3)
| Buy |
3 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$16.00*
(87.13% upside)
Low
12.0
Current: $8.55
High
22.0
Target: 16.00
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | - | - | - | - |
| Operating Income | -12.94 | -8.20 | -7.19 | -7.32 |
| Net Income | -13.75 | -9.31 | -7.48 | -7.30 |
| Shares Outstanding | 13.84 | 1.88 | 1.70 | 1.52 |
| Earnings Per Share | -1.00 | -5.64 | -5.15 | -4.80 |
| Operating Cash Flow | -10.61 | -4.60 | -6.10 | -6.00 |
| Capital Expenditures | -0.83 | -0.02 | -0.05 | -0.25 |
| Free Cash Flow | -11.43 | -4.62 | -6.14 | -6.26 |
| Cash & Equivalents | 12.08 | 0.13 | 0.02 | 0.16 |
| Total Debt | - | 10.57 | 6.03 | - |
| Net Cash / Debt | 12.08 | -10.43 | -6.01 | 0.16 |
| Assets | 13.14 | 1.54 | 0.48 | 0.70 |
| Liabilities | 2.87 | 21.10 | 10.98 | 3.03 |
| Book Value | 10.27 | -19.56 | -10.50 | -2.33 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Soliton, Inc. |
| Country |
United States |
| Employees |
9 |
| CEO |
Christopher Capelli |
Stock Information
| Ticker Symbol |
SOLY |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: SOLY |
| IPO Date |
February 19, 2019 |
Description
Soliton, a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. It is developing a product for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.